CG
DGX icon

Curat Global’s Quest Diagnostics DGX Stock Holding History

Curat Global’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Hold
600
– – 0.1% 128
2026
Q1 		$118K Hold
600
– – 0.12% 119
2025
Q4 		$104K Hold
600
– – 0.12% 127
2025
Q3 		$114K Hold
600
– – 0.11% 126
2025
Q2 		$108K Hold
600
– – 0.1% 130
2025
Q1 		$102K Buy
+600
New +$98.6K 0.12% 139

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Curat Global's DGX Position: Q2 2026 in Review

Curat Global held its Quest Diagnostics (DGX) position steady in Q2 2026 at 600 shares worth $127K. The position accounts for 0.1% of the portfolio, ranked #128.

Curat Global first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Curat Global held 600 shares of Quest Diagnostics worth $127K as of Q2 2026.
  • Curat Global left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.1% of Curat Global's portfolio in Q2 2026, its #128 holding.
  • Curat Global first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.